SYRASyra Health Corp

Nasdaq www.syrahealth.com


$ 1.37 $ 0.00 (0 %)    

Thursday, 23-May-2024 12:35:49 EDT
QQQ $ 454.82 $ -5.54 (-1.2 %)
DIA $ 398.57 $ -5.08 (-1.28 %)
SPY $ 530.36 $ -5.28 (-0.99 %)
TLT $ 91.26 $ -0.74 (-0.8 %)
GLD $ 225.37 $ -3.03 (-1.38 %)
$ 1.37
$ 1.34
$ 0.00 x 0
$ 1.38 x 100
$ 1.31 - $ 1.37
$ 0.81 - $ 8.37
112,078
na
8.9M
$ 4.26
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-09-2024 03-31-2024 10-Q
2 03-25-2024 12-31-2023 10-K
3 11-14-2023 09-30-2023 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 syra-health-q1-eps-022-misses-019-estimate-sales-175m-beat-140m-estimate

Syra Health (NASDAQ:SYRA) reported quarterly losses of $(0.22) per share which missed the analyst consensus estimate of $(0.19)...

 syra-health-bags-5-year-training-contract-from-sedgwick-county-health-department-in-kansas-to-combat-substance-use-disorder-financial-terms-undisclosed

Syra Health Corp. (NASDAQ:SYRA) ("Syra Health" or the "Company"), a healthcare technology company with a missio...

 syra-health-secures-statewide-healthcare-contract-in-missouri

Syra Health Corp. (NASDAQ:SYRA), a healthcare technology company with a mission to improve healthcare by providing innovative s...

 syra-health-q4-eps-016-misses-009-estimate-sales-177m-miss-223m-estimate

Syra Health (NASDAQ:SYRA) reported quarterly losses of $(0.16) per share which missed the analyst consensus estimate of $(0.09)...

 syra-health-expects-fy24-revenue-of-9m-11m-vs-1064m-est

2024 Financial Outlook The Company expects full-year 2024 revenue of $9 to $11 million, representing a growth of 64%-100% ve...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION